BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25395412)

  • 1. Feasibility platform for stroke studies: an online tool to improve eligibility criteria for clinical trials.
    Minnerup J; Trinczek B; Storck M; Hohenberger M; Wilpsbäumer S; Abdul-Rahim AH; Liesirova KT; Broeg-Morvay A; Meisterernst J; Lees KR; Mattle HP; Wersching H; Dziewas R; Schäbitz WR; Schilling M
    Stroke; 2015 Jan; 46(1):137-42. PubMed ID: 25395412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing stroke clinical trial design: estimating the proportion of eligible patients.
    Taylor A; Castle A; Merino JG; Hsia A; Kidwell CS; Warach S
    Stroke; 2010 Oct; 41(10):2236-8. PubMed ID: 20798375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eligibility for Endovascular Trial Enrollment in the 6- to 24-Hour Time Window: Analysis of a Single Comprehensive Stroke Center.
    Jadhav AP; Desai SM; Kenmuir CL; Rocha M; Starr MT; Molyneaux BJ; Gross BA; Jankowitz BT; Jovin TG
    Stroke; 2018 Apr; 49(4):1015-1017. PubMed ID: 29581344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral center.
    Nachtkamp K; Stark J; Kündgen A; Schroeder T; Strupp C; Strapatsas J; Schuler E; Kaivers J; Giagounidis A; Rautenberg C; Aul C; Runde V; Haas R; Kobbe G; Gattermann N; Germing U
    Leuk Res; 2021 Sep; 108():106611. PubMed ID: 33990002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eligibility and Predictors for Acute Revascularization Procedures in a Stroke Center.
    Vanacker P; Lambrou D; Eskandari A; Mosimann PJ; Maghraoui A; Michel P
    Stroke; 2016 Jul; 47(7):1844-9. PubMed ID: 27301945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eligibility for late endovascular treatment using DAWN, DEFUSE-3, and more liberal selection criteria in a stroke center.
    Nannoni S; Strambo D; Sirimarco G; Amiguet M; Vanacker P; Eskandari A; Saliou G; Wintermark M; Dunet V; Michel P
    J Neurointerv Surg; 2020 Sep; 12(9):842-847. PubMed ID: 31772044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Mobile Tool That Semiautomatically Screens Patients for Stroke Clinical Trials.
    Spokoyny I; Lansberg M; Thiessen R; Kemp SM; Aksoy D; Lee Y; Mlynash M; Hirsch KG
    Stroke; 2016 Oct; 47(10):2652-5. PubMed ID: 27608822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding Eligibility in Stroke Prevention Trials to Patients with Early Disability.
    Kasner SE; Siegler JE; Zamzam A; Kleindorfer D;
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2268-2272. PubMed ID: 31160220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential consequences for recruitment, power, and external validity of requirements for additional risk factors for eligibility in randomized controlled trials in secondary prevention of stroke.
    Howard SC; Algra A; Warlow CP; Rothwell PM
    Stroke; 2006 Jan; 37(1):209-15. PubMed ID: 16339480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruiting subjects for acute stroke trials: a meta-analysis.
    Elkins JS; Khatabi T; Fung L; Rootenberg J; Johnston SC
    Stroke; 2006 Jan; 37(1):123-8. PubMed ID: 16322489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASPECTS, Large Vessel Occlusion, and Time of Symptom Onset: Estimation of Eligibility for Endovascular Therapy.
    Mokin M; Pendurthi A; Ljubimov V; Burgin WS; Siddiqui AH; Levy EI; Primiani CT
    Neurosurgery; 2018 Jul; 83(1):122-127. PubMed ID: 29106687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.
    Kaur M; Frahm F; Lu Y; Ascha MS; Guadamuz JS; Dotan E; Gottesman AS; Leybovich BC; Sondhi A; Zhao Y; Meropol NJ; Royce TJ
    NEJM Evid; 2024 Apr; 3(4):EVIDoa2300236. PubMed ID: 38771994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How many stroke patients might be eligible for mechanical thrombectomy?
    Tawil SE; Cheripelli B; Huang X; Moreton F; Kalladka D; MacDougal NJ; McVerry F; Muir KW
    Eur Stroke J; 2016 Dec; 1(4):264-271. PubMed ID: 31008287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unwitnessed stroke: impact of different onset times on eligibility into stroke trials.
    Maas MB; Singhal AB
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):241-3. PubMed ID: 21917477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of selection criteria on recruitment in an interventional stroke trial.
    Hotter B; Jegzentis K; Steinbrink J; Schmidt WU; Endres M; Meisel A; Haverkamp W; Jungehulsing GJ
    Cerebrovasc Dis; 2013; 36(5-6):344-50. PubMed ID: 24192450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data.
    Köpcke F; Lubgan D; Fietkau R; Scholler A; Nau C; Stürzl M; Croner R; Prokosch HU; Toddenroth D
    BMC Med Inform Decis Mak; 2013 Dec; 13():134. PubMed ID: 24321610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The experiences of an acute stroke unit--implications for multicentre acute stroke trials.
    Morris AD; Grosset DG; Squire IB; Lees KR; Bone I; Reid JL
    J Neurol Neurosurg Psychiatry; 1993 Apr; 56(4):352-5. PubMed ID: 8482954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eligibility for mechanical thrombectomy in acute ischemic stroke: A phase IV multi-center screening log registry.
    Tsivgoulis G; Goyal N; Mikulik R; Sharma VK; Katsanos AH; Zand R; Paliwal PR; Roussopoulou A; Volny O; Pandhi A; Zompola C; Elijovich L; Safouris A; Chang J; Alexandrov AV; Alexandrov AW
    J Neurol Sci; 2016 Dec; 371():96-99. PubMed ID: 27871458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for discovering and inferring appropriate eligibility criteria in clinical trial protocols without labeled data.
    Restificar A; Korkontzelos I; Ananiadou S
    BMC Med Inform Decis Mak; 2013; 13 Suppl 1(Suppl 1):S6. PubMed ID: 23566239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.